El Joueidi, Samia http://orcid.org/0000-0001-5749-111X
Bardosh, Kevin
Musoke, Richard
Tilahun, Binyam
Abo Moslim, Maryam
Gourlay, Katie
MacMullin, Alissa
Cook, Victoria J.
Murray, Melanie
Mbaraga, Gilbert
Nsanzimana, Sabin
Lester, Richard
Funding for this research was provided by:
Canadian Institutes of Health Research (332590)
Article History
Received: 5 January 2021
Accepted: 28 September 2021
First Online: 26 October 2021
Declarations
:
: The study was approved by the University of British Columbia’s Clinical Research Ethics Board (H17-03414, H12-03002, H17-00074 & H16-00189), Rwanda Biomedical Center Review Committee, and AMREF in Kenya Ethics and Scientific Review Committee (ESRC). Written consent was obtained from all participants either prior to the mCFIR session or before the beginning of the session. At the beginning of the session, the facilitator collects the consent forms from the participants, including consent to record the discussion.
: Not applicable.
: Principal Investigator Dr. Richard Lester has a financial and professional interest in WelTel Incorporated, a company for which he is Chief Scientific Officer. WelTel Incorporated is subcontracted to provide the SMS software platform and maintenance for the project. WelTel Incorporated is a company founded by Dr. Lester's wife, Dr. Gabrielle Serafini. The company develops software and related technologies to support mobile health (mHealth) through SMS-based, patient engagement platforms. WelTel Inc. has been contracted by this research project to provide the software and the implementation service. As Chief Scientific Officer of WelTel Inc., Dr. Lester advises on the research and development aspects of WelTel Inc. and communicates with the scientific and customer communities concerning the evidence ¬base and utility of the software.